Undernutrition in both its acute and chronic forms (wasting and stunting) is strongly inversely correlated with the wealth of nations. Consequently, as many low- and middle-income countries (LMICs) achieve economic advancement and pass through the so-called “nutrition transition,” their rates of undernutrition decline. Many countries successfully achieved the Millennium Development Goal of halving undernutrition and whole continents have been transformed in recent decades. The exception is Africa where the slower rates of decline in the prevalence of undernutrition has been overtaken by population growth so that the absolute number of stunted children is rising. In many regions, economic transition is causing a rapid increase in the number of overweight and obese people. The rapidity of this rise is such that many nations bear the simultaneous burdens of under- and overnutrition; termed the “double burden” of malnutrition. This double burden, accompanied as it is by the unfinished agenda of high levels of infectious diseases, is crippling the health systems of many LMICs and thus requires urgent attention. Although the prognosis looks threatening for many poor countries, they have the advantage of being able to learn from the mistakes made by other nations that have passed through the transition before them. Concerted action across many arms of government would achieve huge future dividends in health and wealth for any nations that can grasp the challenge.

Keywords:
Malnutrition, Obesity, Double burden
1.
FAO, IFAD, UNICEF, WFP, WHO: The State of Food Security and Nutrition in the World 2017. Building Resilience for Peace and Food Security. Rome, FAO, 2017.
2.
Prentice AM: The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35: 93–99.
3.
Black RE, Victora CG, Walker SP, et al: Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013; 382: 427–451.
4.
Victora CG, De Onis M, Hallal PC, et al: Worldwide timing of growth faltering: revisiting implications interventions. Pediatrics 2010; 125:e473–e480.
5.
Arnold BF, Null C, Luby SP, et al. Cluster-randomised controlled trials of individual and combined water, sanitation, hygiene and nutritional interventions in rural Bangladesh and Kenya: the WASH Benefits study design and rationale. BMJ Open 2013; 3:e003476.
6.
Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial Team, Humphrey JH, Jones AD, Manges A, Mangwadu G, Maluccio JA, Mbuya MN, Moulton LH, Ntozini R, Prendergast AJ, Stoltzfus RJ, Tielsch JM: The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial: rationale, design, and methods. Clin Infect Dis 2015; 61(suppl 7):S685–S702.
7.
Null C, Stewart CP, Pickering AJ, Dentz HN, Arnold BF, Arnold CD, Benjamin-Chung J, Clasen T, Dewey KG, Fernald LCH, Hubbard AE, Kariger P, Lin A, Luby SP, Mertens A, Njenga SM, Nyambane G, Ram PK, Colford JM Jr: Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Kenya: a cluster-randomised controlled trial. Lancet Glob Health 2018; 6:e316–e329.
8.
Luby SP, Rahman M, Arnold BF, Unicomb L, Ashraf S, Winch PJ, Stewart CP, Begum F, Hussain F, Benjamin-Chung J, Leontsini E, Naser AM, Parvez SM, Hubbard AE, Lin A, Nizame FA, Jannat K, Ercumen A, Ram PK, Das KK, Abedin J, Clasen TF, Dewey KG, Fernald LC, Null C, Ahmed T, Colford JM Jr: Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Bangladesh: a cluster randomised controlled trial. Lancet Glob Health 2018; 6:e302–e315.
9.
Prentice AM, Jebb SA: Obesity in Britain: gluttony or sloth? BMJ 1995; 311: 437–439.
10.
Kühnen P, Handke D, Waterland RA, et al: Interindividual variation in DNA methylation at a putative POMC metastable epiallele is associated with obesity. Cell Metab 2016; 24: 502–509.
11.
Fleming TP, Watkins A, Velazquez MA, et al: Origins of lifetime health around the time of conception: causes and consequences. Lancet, in press.
12.
van der Sande MA, Ceesay SM, Milligan PJ, et al: Obesity and undernutrition and cardiovascular risk factors in rural and urban Gambian communities. Am J Public Health 2001; 91: 1641–1644.
13.
Siervo M, Grey P, Nyan OA, Prentice AM: A pilot study on body image, attractiveness and body size in Gambians living in an urban community. Eat Weight Disord 2006; 11: 100–109.
14.
Kimani-Murage EW, Muthuri SK, Oti SO, Mutua MK, van de Vijver S, Kyobutungi C: Evidence of a double burden of malnutrition in urban poor settings in Nairobi, Kenya. PLoS One 2015; 10:e0129943.
15.
World Health Organization: Global Action Plan for the Prevention and Control of Noncommunicable Diseases. WHO, 2013. http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236_eng.pdf?ua=1.
16.
World Health Organization: Ending Childhood Obesity. WHO, 2016. http://apps.who.int/iris/bitstream/10665/204176/1/9789241510066_eng.pdf?ua=1&ua=1.
17.
World Health Organization: Fiscal Policies for Diet and Prevention of Noncommunicable Diseases. WHO, 2016. http://apps.who.int/iris/bitstream/10665/250131/1/9789241511247-eng.pdf?ua=1.
18.
World Health Organization: Development of a Draft Action Plan to Promote Physical Activity. WHO, 2018. http://www.who.int/ncds/governance/physical_activity_plan/en/.
19.
Christian P, Lee SE, Donahue Angel M, et al: Risk of childhood undernutrition related to small-for-gestational age and preterm birth in low- and middle-income countries. Int J Epidemiol 2013; 42: 1340–55.
20.
Hales CN, Barker DJ: Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595–601.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.